Nemolizumab: a new key player in the treatment of prurigo nodularis. Reich A. Br J Dermatol 2024;191:154-155.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Reich A. Nemolizumab: a new key player in the treatment of prurigo nodularis. Br J Dermatol 2024;191:154-155.
PMID: 38703061